Electronic patient-reported outcome platforms used in hematological cancers: a systematic review.
Support Care CancerSep 25, 2026 (epub)
Jessica Nikolovski, Marika Franklin, Eliza A Hawkes et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review examined electronic patient-reported outcome measures (ePROMs) in hematological cancers, identifying 14 platforms from 18 studies. The review found that most platforms were well-accepted by patients and clinicians, with high engagement rates exceeding 80%. Positive outcomes included reduced symptom burden and improved communication.
Key findings
- Fourteen ePROM platforms were identified across 18 studies, with 13 unique platforms reported.
- High patient engagement was noted, with completion rates exceeding 80%.
- Usability was reported to be high, with most platforms acceptable to both patients and clinicians.
- Positive outcomes included reduced symptom burden and improved treatment adherence.
Why it matters
Understanding the effectiveness and acceptance of ePROMs in hematological cancers can enhance patient care by improving symptom management and communication between patients and healthcare providers.